The National Cancer Institute’s SBIR Development Center virtual workshop on SBIR/STTR programs, eligibility, resources, and initiatives. 

Missed it? Watch the recording of this program on our YouTube Channel.

About this Event

NCI SBIR/STTR Workshop
The Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive financing for early stage companies. The National Cancer Institute’s SBIR Development Center provides funding, networking, and mentoring support for small businesses developing innovative cancer technologies. In fiscal year 2020, NCI SBIR will provide $179 million to small businesses to translate their innovation from lab to market. NCI SBIR program directors Monique Pond and Jonathan Franca-Koh will be speaking at this event, covering:

Overview of SBIR/STTR eligibility requirements
-NIH SBIR/STTR process and new cancer-focused grant funding opportunities from NCI
-NIH/NCI resources for applicants – Applicant Assistant Program (free!)
-NCI SBIR/STTR initiatives such as NIH Innovation Corps (I-Corps™), peer learning and networking opportunities, and commercialization workshops
-NCI Investor Initiative to help NCI SBIR-funded companies to connect with investors, venture capitalists, and strategic partners from the biotech and pharmaceutical industries

Following the presentations, selected companies will have the opportunity to virtually meet one-on-one with program directors. To be considered for a one-on-one meeting, please check the box on the order form and we will follow up with more information. Space is limited; apply for a one-on-one meeting no later than May 7, 2021.

Missed it? Watch the recording of this program on our YouTube Channel.

Event Agenda:

10:00 a.m. – 11:30 a.m. Presentation and Q&A

11:30 a.m. – 11:40 a.m. Break

11:40 a.m. – 3:00 p.m. 1-on-1 Meetings for Pre-selected Companies

About the Presenters:

Monique Pond, PhD
Program Director
SBIR Development Center, National Cancer Institute

Dr. Monique Pond is a Program Director in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI). She manages a portfolio of grants and contracts to small businesses developing novel cancer therapeutics, digital health technologies, and therapeutic devices. Additionally, Monique manages the development of new SBIR Development Center initiatives to assist small businesses in navigating the regulatory pathways for their technologies. She initially joined the NCI SBIR Development Center in 2018 as a Science & Technology Policy Fellow with the American Association for the Advancement of Science.

Prior to joining NCI, Dr. Pond spent several years as a regulatory medical writer and consultant at a small start-up where she provided clients with regulatory support for FDA and EMA submissions. She was awarded a National Research Council Fellowship at the National Institute of Standards and Technology where her postdoctoral research focused on the development of bioanalytical tools. Monique earned a Ph.D. in chemistry from the Pennsylvania State University and a B.S. in chemistry from the University of Texas at Austin.

Jonathan Franca-Koh, PhD
Program Director
SBIR Development Center, National Cancer Institute

Dr. Jonathan Franca-Koh is a Program Director at the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center. Jonathan manages SBIR & STTR grants and contracts with a focus on cancer therapeutics and novel tools for research and drug discovery. He provides oversight throughout the award period and mentors applicants and awardees in developing their technology goals and commercialization strategy. Additionally, he plays an active role in several center initiatives, including recent investor forums, workshops, targeted funding opportunities, and represents the NCI on the trans-NIH REACH program. Prior to joining the SBIR Development Center, Jonathan was a Program Director at the NCI Division of Cancer Biology and Center for Strategic Scientific Initiatives, overseeing the Physical Sciences-Oncology Centers (PS-OC) program, a network of interdisciplinary centers that brought together physical scientists and cancer biologists. Jonathan received his PhD in Cell and Molecular Biology from the University of London’s Institute of Cancer Research in 2003, and completed post-doctoral research at Johns Hopkins University and the J. Craig Venter Institute. In 2014 he completed his MBA from Johns Hopkins University, focusing on finance and health care innovation.

This event is organized by:
NIH National Cancer Institute | Oregon Clinical & Translational Research Institute | Knight Cancer Institute CEDAR | Oregon Bioscience Incubator/OTRADI

Missed it? Watch the recording of this program on our YouTube Channel.